These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28459958)

  • 1. Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).
    Pang PS; Butler J; Collins SP; Cotter G; Davison BA; Ezekowitz JA; Filippatos G; Levy PD; Metra M; Ponikowski P; Teerlink JR; Voors AA; Bharucha D; Goin K; Soergel DG; Felker GM
    Eur Heart J; 2017 Aug; 38(30):2364-2373. PubMed ID: 28459958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure).
    Felker GM; Butler J; Collins SP; Cotter G; Davison BA; Ezekowitz JA; Filippatos G; Levy PD; Metra M; Ponikowski P; Soergel DG; Teerlink JR; Violin JD; Voors AA; Pang PS
    JACC Heart Fail; 2015 Mar; 3(3):193-201. PubMed ID: 25650371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.
    Cotter G; Davison BA; Butler J; Collins SP; Ezekowitz JA; Felker GM; Filippatos G; Levy PD; Metra M; Ponikowski P; Teerlink JR; Voors AA; Senger S; Bharucha D; Goin K; Soergel DG; Pang PS
    Clin Res Cardiol; 2018 Feb; 107(2):170-181. PubMed ID: 28986703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.
    Teerlink JR; Metra M; Felker GM; Ponikowski P; Voors AA; Weatherley BD; Marmor A; Katz A; Grzybowski J; Unemori E; Teichman SL; Cotter G
    Lancet; 2009 Apr; 373(9673):1429-39. PubMed ID: 19329178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
    Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
    Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M;
    Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of the RELAXin in acute heart failure study.
    Ponikowski P; Metra M; Teerlink JR; Unemori E; Felker GM; Voors AA; Filippatos G; Greenberg B; Teichman SL; Severin T; Mueller-Velten G; Cotter G; Davison BA
    Am Heart J; 2012 Feb; 163(2):149-55.e1. PubMed ID: 22305830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies).
    Davison BA; Takagi K; Edwards C; Adams KF; Butler J; Collins SP; Dorobantu MI; Ezekowitz JA; Filippatos G; Greenberg BH; Levy PD; Masip J; Metra M; Pang PS; Ponikowski P; Severin TM; Teerlink JR; Teichman SL; Voors AA; Werdan K; Cotter G
    Am J Cardiol; 2022 Oct; 180():72-80. PubMed ID: 35933224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
    Sato N; Lam CS; Teerlink JR; Greenberg BH; Tsutsui H; Oh BH; Zhang J; Lefkowitz M; Hua TA; Holbro T; Marshood M; Wang XL; Ge J
    J Card Fail; 2017 Jan; 23(1):63-71. PubMed ID: 27825893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.
    Teerlink JR; Felker GM; McMurray JJV; Ponikowski P; Metra M; Filippatos GS; Ezekowitz JA; Dickstein K; Cleland JGF; Kim JB; Lei L; Knusel B; Wolff AA; Malik FI; Wasserman SM;
    J Am Coll Cardiol; 2016 Mar; 67(12):1444-1455. PubMed ID: 27012405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First clinical experience with TRV027: pharmacokinetics and pharmacodynamics in healthy volunteers.
    Soergel DG; Subach RA; Cowan CL; Violin JD; Lark MW
    J Clin Pharmacol; 2013 Sep; 53(9):892-9. PubMed ID: 23813302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased Agonism of the Angiotensin II Type I Receptor.
    Ikeda Y; Kumagai H; Motozawa Y; Suzuki J; Komuro I
    Int Heart J; 2015; 56(5):485-8. PubMed ID: 26180022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
    Ponikowski P; Kirwan BA; Anker SD; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Haboubi T; Keren A; Khintibidze I; Kragten H; Martinez FA; McDonagh T; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Jankowska EA
    Eur J Heart Fail; 2019 Dec; 21(12):1651-1658. PubMed ID: 31883356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial.
    Cice G; Di Benedetto A; D'Isa S; D'Andrea A; Marcelli D; Gatti E; Calabrò R
    J Am Coll Cardiol; 2010 Nov; 56(21):1701-8. PubMed ID: 21070920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
    Voors AA; Davison BA; Teerlink JR; Felker GM; Cotter G; Filippatos G; Greenberg BH; Pang PS; Levin B; Hua TA; Severin T; Ponikowski P; Metra M;
    Eur J Heart Fail; 2014 Nov; 16(11):1230-40. PubMed ID: 25287144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU.
    Maggioni AP; López-Sendón J; Nielsen OW; Hallén J; Aalamian-Mattheis M; Wang Y; Ertl G
    Eur J Heart Fail; 2019 Mar; 21(3):322-333. PubMed ID: 30604559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the AUGUST-AHF Study.
    Zhang J; Sun Y; Zhou K; Zhang X; Chen Y; Hu J; Zhong C; Liu Y; Shang H
    ESC Heart Fail; 2020 Oct; 7(5):3124-3133. PubMed ID: 32567238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
    Metra M; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld L; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Prescott MF; Edwards C; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin T; Teerlink JR;
    J Am Coll Cardiol; 2013 Jan; 61(2):196-206. PubMed ID: 23273292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study.
    Felker GM; McMurray JJV; Cleland JG; O'Connor CM; Teerlink JR; Voors AA; Belohlavek J; Böhm M; Borentain M; Bueno H; Cole RT; DeSouza MM; Ezekowitz JA; Filippatos G; Lang NN; Kessler PD; Martinez FA; Mebazaa A; Metra M; Mosterd A; Pang PS; Ponikowski P; Sato N; Seiffert D; Ye J
    JACC Heart Fail; 2021 Feb; 9(2):146-157. PubMed ID: 33248986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF).
    Damman K; Beusekamp JC; Boorsma EM; Swart HP; Smilde TDJ; Elvan A; van Eck JWM; Heerspink HJL; Voors AA
    Eur J Heart Fail; 2020 Apr; 22(4):713-722. PubMed ID: 31912605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.